Intracellular zinc in insulin secretion and action: A determinant of diabetes risk?

Proceedings of the Nutrition Society

Volumn 75, Issue 1, 2016, Pages 61-72

  Rutter, Guy A ^a   Chabosseau, Pauline ^a   Bellomo, Elisa A ^b   Maret, Wolfgang ^b   Mitchell, Ryan K ^a   Hodson, David J ^a   Solomou, Antonia ^a   Hu, Ming ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes; Imaging; Insulin; Zinc; Zinc transporter 8

Indexed keywords

COCARBOXYLASE; COMPLEMENTARY DNA; CYANOCOBALAMIN; FOLIC ACID; GLUCONATE ZINC; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEMOGLOBIN A1C; HOMOCYSTEINE; INSULIN RECEPTOR SUBSTRATE; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG; ZINC; ZINC ION; ZINC SULFATE; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ALOPECIA; CELL COMPARTMENTALIZATION; CELL FUNCTION; CONFERENCE PAPER; CRYSTAL STRUCTURE; CYTOSOL; DIABETES MELLITUS; DIARRHEA; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUTATHIONE METABOLISM; HUMAN; IN VIVO STUDY; INSULIN RELEASE; MALNUTRITION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROTEIN TERTIARY STRUCTURE; RISK FACTOR; SECRETORY GRANULE; SIGNAL TRANSDUCTION; ZINC BLOOD LEVEL;

EID: 84959455225     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665115003237     Document Type: Conference Paper

References (109)

1. Prasad AS (2013) Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr 4, 176-190.
2. Magneson GR, Puvathingal JM & Ray WJ Jr (1987) The concentrations of free Mg2+ and free Zn2+ in equine blood plasma. J Biol Chem 262, 11140-11148.
3. Andreini C, Banci LF, Bertini IF et al. (2006) Counting the zinc-proteins encoded in the human genome. J Proteome Res 5, 196-201.
4. Maret W (2013) Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr 4, 82-91.
5. Huang L & Tepaamorndech S (2013) The SLC30 family of zinc transporters-a review of current understanDing of their biological and pathophysiological roles. Mol Aspects Med 34, 548-560.
6. Jeong J & Eide DJ (2013) The SLC39 family of zinc transporters. Mol Aspects Med 34, 612-619.
7. Vinkenborg JL, Nicolson TJ, Bellomo EA et al. (2009) Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis. Nat Methods 6, 737-740.
8. Chabosseau P, Tuncay E, Meur G et al. (2014) Mitochondrial and ER-targeted eCALWY probes reveal high levels of free Zn2+. ACS Chem Biol 9, 2111-2120.
9. Taylor KM, Hiscox S, Nicholson RI et al. (2012) Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci Signal 5, ra11.
10. Krezel A, Hao Q & Maret W (2007) The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch Biochem Biophys 463, 188-200.
11. Li Y & Maret W (2009) Transient fluctuations of intracellular zinc ions in cell proliferation. Exp Cell Res 315, 2463-2470.
12. Hasan R, Rink L & Haase H (2013) Zinc signals in neutrophil granulocytes are required for the formation of neutrophil extracellular traps. Innate Immun 19, 253-264.
13. Yamasaki S, Sakata-Sogawa K, Hasegawa A et al. (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177, 637-645.
14. Gilon P, Chae HY, Rutter GA et al. (2014) Calcium signaling in pancreatic beta-cells in health and in Type 2 diabetes. Cell Calcium 56, 340-361.
15. Laity JH & Andrews GK (2007) UnderstanDing the mechanisms of zinc-sensing by metal-response element binDing transcription factor-1 (MTF-1). Arch Biochem Biophys 463, 201-210.
16. DeanKM, QinY & PalmerAE (2012) Visualizing metal ions in cells: an overviewof analytical techniques, approaches, and probes. Biochim Biophys Acta 1823, 1406-1415.
17. de Silva AP, Fox DB, Moody TS et al. (2001) The development of molecular fluorescent switches. Trends Biotechnol 19, 29-34.
18. de Silva AP, Moody TS & Wright GD (2009) Fluorescent PET (photoinduced electron transfer) sensors as potent analytical tools. The Analyst 134, 2385-2393.
19. Carter KP, Young AM & Palmer AE (2014) Fluorescent sensors for measuring metal ions in living systems. Chem Rev 114, 4564-4601.
20. Zalewski PD, Forbes IJ & Betts WH (1993) Correlation of apoptosis with change in intracellular labile Zn (II) using zinquin [ (2-methyl-8-p-toluenesulphonamido-6-quinolyloxy) acetic acid], a new specific fluorescent probe for Zn (II). The Biochem J 296, 403-408.
21. Gee KR, Zhou ZL, Qian WJ et al. (2002) Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. J Am Chem Soc 124, 776-778.
22. Tsien RY (1981) A non-disruptive technique for loaDing calcium buffers and indicators into cells. Nature 290, 527-528.
23. Qin Y, Miranda JG, Stoddard CI et al. (2013) Direct comparison of a genetically encoded sensor and small molecule indicator: implications for quantification of cytosolic Zn (2+). ACS Chem Biol 8, 2366-2371.
24. Thompson K, Dockery P & Horobin RW (2012) Predicting and avoiDing subcellular compartmentalization artifacts arising from acetoxymethyl ester calcium imaging probes. The case of fluo-3 AM and a general account of the phenomenon incluDing a problem avoidance chart. Biotech Histochem: Official Pub Biological Stain Commission 87, 468-483.
25. Chyan W, Zhang DY, Lippard SJ et al. (2014) Reaction-based fluorescent sensor for investigating mobile Zn2+ in mitochondria of healthy versus cancerous prostate cells. Proc Natl Acad Sci 111, 143-148.
26. Li D, Chen S, Bellomo EA et al. (2011) Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR). Proc Natl Acad Sci USA 108, 21063-21068.
27. Pancholi J, Hodson DJ, Kobe K et al (2014) Biologically targeted probes for zinc: A diversity-oriented modular Click-SNAR Approach 5, 3528-3535
28. Hessels AM & Merkx M (2015) Genetically-encoded FRET-based sensors for monitoring Zn (2+) in living cells. Metallomics: Integr Biometal Sci 7, 258-266.
29. Dittmer PJ, Miranda JG, Gorski JA et al. (2009) Genetically encoded sensors to elucidate spatial distribution of cellular zinc. J Biol Chem 284, 16289-16297.
30. Qin Y, Dittmer PJ, Park JG et al. (2011) Measuring steady-state and dynamic endoplasmic reticulum and Golgi Zn2+ with genetically encoded sensors. Proc Natl Acad Sci USA 108, 7351-7356.
31. Park JG, Qin Y, Galati DF et al. (2012) New sensors for quantitative measurement of mitochondrial Zn (2+). ACS Chem Biol 7, 1636-1640.
32. Miranda JG, Weaver AL, Qin Y et al. (2012) New alternately colored FRET sensors for simultaneous monitoring of Zn (2) (+) in multiple cellular locations. PLoS ONE 7, e49371.
33. Bellomo EA, Meur G & Rutter GA (2011) Glucose regulates free cytosolic Zn2+ concentration, Slc39 (ZiP) and metallothionein gene expression in primary pancreatic islet {beta}-cells. J Biol Chem 286, 25778-25789.
34. Lindenburg LH, Hessels AM, Ebberink EH et al. (2013) Robust red FRET sensors using self-associating fluorescent domains. ACS Chem Biol 8, 2133-2139.
35. Bozym RA, Thompson RB, Stoddard AK et al. (2006) Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor. ACS Chem Biol 1, 103-111.
36. Hurst TK, Wang D, Thompson RB et al. (2010) Carbonic anhydrase II-based metal ion sensing: advances and new perspectives. Biochimica et Biophysica acta 1804, 393-403.
37. Scott DA & Fisher AM (1938) The Insulin and the zinc content of normal and diabetic pancreas. J Clin Invest 17, 725-728.
38. el-Yazigi A, Hannan N & Raines DA (1993) Effect of diabetic state and related disorders on the urinary excretion of magnesium and zinc in patients. Diabetes Res 22, 67-75.
39. Garg VK, Gupta R & Goyal RK (1994) Hypozincemia in diabetes mellitus. J Assoc Physicians India 42, 720-721.
40. Basaki M, Saeb M, Nazifi S et al. (2012) Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res 148, 161-164.
41. Jansen J, Rosenkranz E, Overbeck S et al. (2012) Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J Nutr Biochem 23, 1458-1466.
42. Dunn MF (2005) Zinc-ligand interactions modulate assembly and stability of the insulin hexamer-a review. Biometals 18, 295-303.
43. Cruz KJ, de Oliveira AR & Marreiro DN (2015) Antioxidant role of zinc in diabetes mellitus. World J Diabetes 6, 333-337.
44. Begin-Heick N, Dalpe-Scott M, Rowe J et al. (1985) Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 34, 179-184.
45. Simon SF & Taylor CG (2001) Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med (Maywood) 226, 43-51.
46. Wang X, Li H, Fan Z et al. (2012) Effect of zinc supplementation on type 2 diabetes parameters and liver metallothionein expressions in Wistar rats. J Physiol Biochem 68, 563-572.
47. Vardatsikos G, Pandey NR & Srivastava AK (2013) Insulino-mimetic and anti-diabetic effects of zinc. J Inorg Biochem 120, 8-17. Epub@2012 Dec 3. , 8-17.
48. Hutton JC, Penn EJ & Peshavaria M (1983) Lowmolecular-weight constituents of isolated insulin-secretory vesicles. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem J 210, 297-305.
49. Sondergaard LG, Stoltenberg M, Doering P et al. (2006) Zinc ions in the endocrine and exocrine pancreas of zinc deficient rats. Histol Histopathol 21, 619-625.
50. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46, 3-19.
51. Rutter GA & Parton LE (2008) The beta-cell in type 2 diabetes and in obesity. Front Horm Res 36, 118-134.
52. Butler AE, Janson J, Bonner-Weir S et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110.
53. Rahier J, Guiot Y, Goebbels RM et al. (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10, 32-42.
54. Stasiuk GJ, Minuzzi F, Sae-Hen M et al. (2015) Dual-modal MR/fluorescent zinc probes towards pancreatic beta cell mass imaging. Chemistry 21, 5023-5033.
55. Arvan P & Halban PA (2004) Sorting ourselves out: seeking consensus on trafficking in the beta-cell. Traffic 5, 53-61.
56. Rutter GA, Pullen TJ, Hodson DJ et al. (2015) Pancreatic beta cell identity, glucose sensing and the control of insulin secretion. Biochem J 466, 202-218.
57. Rutter GA, Pralong W-F & Wollheim CB (1992) Regulation of mitochondrial glycerol phosphate dehydrogenase activity by Ca2+ within electropermeabilized insulin-secreting cells (INS1). Biochimica et Biophysica Acta-Bioenergetics 1175, 107-113.
58. Tarasov AI, Ravier MA, Semplici F et al. (2012) The mitochondrial Ca2+ uniporter MCU is essential for glucoseinduced ATP increases in pancreatic â-cells. PLoS ONE 7, e39722.
59. Rutter GA, Theler J-M, Li G et al. (1994) Ca2+ stores in insulin-secreting cells: lack of effect of cADP ribose. Cell Calcium 16, 71-80.
60. Rutter GA (2004) Visualising insulin secretion. The minkowski lecture 2004. Diabetologia 47, 1861-1872.
61. Chimienti F, Devergnas S, Favier A et al. (2004) Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53, 2330-2337.
62. Wenzlau JM, Juhl K, Yu L et al. (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104, 17040-17045.
63. Sladek R, Rocheleau G, Rung J et al. (2007) A genomewide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
64. Staiger H, Machicao F, Stefan N et al. (2007) Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS ONE 2, e832.
65. Kirchhoff K, Machicao F, Haupt A et al. (2008) Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51, 597-601.
66. Dimas AS, Lagou V, Barker A et al. (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158-2171.
67. Ruchat SM, Elks CE, Loos RJ et al. (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46, 217-226.
68. Cauchi S, Del GS, Choquet H et al. (2010) Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab 100, 77-82.
69. Kanoni S, Nettleton JA, Hivert MF et al. (2011) Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-Cohort meta-analysis. Diabetes 60, 2407-2416.
70. Flannick J, Thorleifsson G, Beer NL et al. (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 46, 357-363.
71. Chao Y & Fu D (2004) Thermodynamic studies of the mechanism of metal binDing to the Escherichia coli zinc transporter YiiP. J Biol Chem 279, 17173-17180.
72. Nicolson TJ, Bellomo EA, Wijesekara N et al. (2009) Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 58, 2070-2083.
73. Weijers RN (2010) Three-dimensional structure of betacell-specific zinc transporter, ZnT-8, predicted from the type 2 diabetes-associated gene variant SLC30A8 R325W. Diabetol Metab Syndr 2, 33.
74. Kim H, Toyofuku Y, Lynn FC et al. (2010) Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 16, 804-808.
75. Lemaire K, Ravier MA, Schraenen A et al. (2009) Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci USA 106, 14872-14877.
76. Pound LD, Sarkar SA, Benninger RK et al. (2009) Deletion of themouse Slc30a8 gene encoDing zinc transporter-8 results in impaired insulin secretion. Biochem J 421, 371-376.
77. Gerber PA, Bellomo EA, Hodson DJ et al. (2014) Hypoxia lowers SLC30A8/ZnT8 expression and free cytosolic Zn2+ in pancreatic beta cells. Diabetologia 57, 1635-1644.
78. Wijesekara N, Dai FF, Hardy AB et al. (2010) Beta cell specific ZnT8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 53, 1656-1668.
79. Tamaki M, Fujitani Y, Hara A et al. (2013) The diabetessusceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest 123, 4513-4524.
80. Wicksteed B, Brissova M, Yan W et al. (2010) Conditional gene targeting in mouse pancreatic {beta}-cells: analysis of ectopic cre transgene expression in the brain. Diabetes 59, 3090-3098.
81. Rutter GA (2010) Think zinc: new roles for zinc in the control of insulin secretion. Islets 2, 1-2.
82. Rutter GA & Chimienti F (2015) SLC30A8 mutations in type 2 diabetes. Diabetologia 58, 31-36.
83. Hardy AB, Wijesekara N, Genkin I et al. (2012) Effects of high-fat diet feeDing on Znt8-null mice: differences between beta-cell and global knockout of Znt8. Am J Physiol Endocrinol Metab 302, E1084-E1096.
84. Brouwers B, de FG, Osipovich AB et al. (2014) Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. Cell Metab 20, 979-990.
85. Thorens B, Tarussio D, Maestro MA et al. (2015) Ins1 knock-in mice for beta cell-specific gene recombination. Diabetologia 58, 558-656.
86. MitchellRK, HuM, MeurGet al. (2015) Reciprocal changes in glucose tolerance after pancreatic beta cell-selective deletion or over-expression of Slc30a8/ZnT8 in mice Diabetologia (In the Press).
87. Pullen TJ, Sylow L, Sun G et al. (2012) Over-expression of Monocarboxylate transporter-1 (Slc16a1) in the pancreatic â-cell leads to relative hyperinsulinism during exercise. Diabetes 61, 1719-1725.
88. Slepchenko KG, James CB & Li YV (2013) Inhibitory effect of zinc on glucose-stimulated zinc/insulin secretion in an insulin-secreting beta-cell line. Exp Physiol 98, 1301-1311.
89. Schweiger M, Steffl M & Amselgruber WM (2013) The zinc transporter ZnT8 (slc30A8) is expressed exclusively in beta cells in porcine islets. Histochem Cell Biol 140, 677-684.
90. Souza SC, Qui L, Inouye K et al. (2008) Zinc transporter ZnT-8 regulates insulin and glucagon secretion in Min6 and alphaTC1-9 pancreatic cell lines. Diabetologia 51, S206.
91. Ishihara H, Maechler P, Gjinovci A et al. (2003) Islet betacell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 5, 330-335.
92. Franklin I, Gromada J, Gjinovci A et al. (2005) Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54, 1808-1815.
93. Gyulkhandanyan AV, Lu H, Lee SC et al. (2008) Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem 283, 10184-10197.
94. Hardy AB, Serino AS, Wijesekara N et al. (2011) Regulation of glucagon secretion by zinc: lessons from the beta cell-specific Znt8 knockout mouse model. Diabetes Obes Metab 13 (Suppl. 1) , 112-117.
95. Solomou A, Meur G, Bellomo EA et al. (2015) The zinc transporter Slc30a8/ZnT8 is required in a subpopulation of pancreatic á cells for hypoglycemia-induced glucagon secretion. J Biol Chem (Epublication ahead of print version).
96. Lee J & Pilch PF (1994) The insulin receptor: structure, function, and signaling. Am J Physiol 266, C319-C334.
97. Kanzaki M (2006) Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J 53, 267-293.
98. Coulston L & Dandona P (1980) Insulin-like effect of zinc on adipocytes. Diabetes 29, 665-667.
99. Miranda ER & Dey CS (2004) Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biol Trace Elem Res 101, 19-36.
100. Haase H & Maret W (2003) Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/ insulin-like growth factor-1 signaling. Exp Cell Res 291, 289-298.
101. Tang X & Shay NF (2001) Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 131, 1414-1420.
102. Wu W, Wang X, Zhang W et al. (2003) Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem 278, 28258-28263.
103. Plum LM, Brieger A, Engelhardt G et al. (2014) PTEN-inhibition by zinc ions augments interleukin-2-mediated Akt phosphorylation. Metallomics 6, 1277-1287.
104. Bellomo E, Massarotti A, Hogstrand C et al. (2014) Zinc ions modulate protein tyrosine phosphatase 1B activity. Metallomics 6, 1229-1239.
105. Barthel A, Ostrakhovitch EA, Walter PL et al. (2007) Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463, 175-182.
106. Myers SA, Nield A, Chew GS et al. (2013) The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells. PLoS ONE 8, e79316.
107. Zhu K, Nie S, Li C et al. (2013) Antidiabetic and pancreas-protective effects of zinc threoninate chelate in diabetic rats may be associated with its antioxidative stress ability. Biol Trace Elem Res 153, 291-298.
108. Karatug A, Kaptan E, Bolkent S et al. (2013) Alterations in kidney tissue following zinc supplementation to STZinduced diabetic rats. J Trace Elem Med Biol 27, 52-57.
109. Pound LD, Sarkar SA, Ustione A et al. (2012) The physiological effects of deleting the mouse slc30a8 gene encoDing zinc transporter-8 are influenced by gender and genetic background. PLoS ONE 7, e40972.